Protalix Biotherapeutics, Inc.
Ticker: PLX
| Insider | Title |
|---|---|
| Aharon Schwartz | Director |
| Amos Bar-shalev | Director |
| Dan Oren | 10% or greater ownership |
| Dror Bashan | PRESIDENT AND CEO, Director |
| Eyal Rubin | Sr. VP and CFO |
| Gwen A Melincoff | Director |
| Pharma Technologies Ltd. Dexcel | 10% or greater ownership |
| Pol F Boudes | Director |
| Yael Hayon | VP, Research Development |
| Yaron Naos | Sr. VP, Operations |
| Zeev Bronfeld | Director |
| Zvi Shmuel Ben | Director |